Company Filing History:
1 out of 96 
1 out of 685 
1 out of 7 Years Active: 2016
Title: Innovations by Ya-Hui Wang in Cancer Treatment
Introduction
Ya-Hui Wang is a notable inventor based in New Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the inhibition of TMCC3, a protein associated with cancer stem cells.
Latest Patents
Ya-Hui Wang holds a patent titled "Methods for suppressing cancer by inhibition of TMCC3." This patent describes a method for treating cancer that involves administering an antibody against the transmembrane and coiled-coil domains protein 3 (TMCC3). The antibody binds to specific epitopes in the extracellular and intercoil domains of TMCC3. Additionally, the patent outlines a method for diagnosing or assessing cancer conditions by evaluating the expression or activity levels of TMCC3 in a sample.
Career Highlights
Throughout his career, Ya-Hui Wang has worked with prominent institutions such as the Development Center for Biotechnology and Academia Sinica. His research has focused on developing innovative methods to combat cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Ya-Hui Wang has collaborated with notable colleagues, including Alice L. Yu and John Yu. These partnerships have contributed to the advancement of his research and the development of effective cancer treatment methods.
Conclusion
Ya-Hui Wang's innovative work in cancer treatment through the inhibition of TMCC3 highlights his significant contributions to medical research. His patented methods offer promising avenues for diagnosing and treating cancer, reflecting his commitment to advancing healthcare solutions.